KYVERNA THERAPEUTICS INC (KYTX) Top Institutional Shareholders
KYVERNA THERAPEUTICS INC (KYTX) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $286.94M in KYTX holdings during the latest filing period.
Gordonmd Global Investments Lp is currently the largest disclosed institutional shareholder of KYTX tracked by InsiderSet, reporting ownership valued at approximately $36.63M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $34.13M, representing an estimated loss of -6.84% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 64% of the total disclosed KYTX value among the investors covered in this analysis. Major shareholders include Gordonmd Global Investments Lp, Gilead Sciences, Inc., Bain Capital Life Sciences Investors, Llc, and several other long-term asset managers with concentrated positions in KYVERNA THERAPEUTICS INC (KYTX).
This page ranks the largest institutional KYTX shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
109
Total Reported Value
$286.94M
Largest Holder
Gordonmd Global Investments Lp
Largest Position
$36.63M
Insider Transactions (90d)
0
Latest Filing Quarter
Q1 2026
New Institutional Positions
125
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Gordonmd Global Investments Lp | 25.51% | 4,244,818 | $36,632,779 | $34,128,337 | -$2,504,442 | -6.84% | |
| Gilead Sciences, Inc. | 1.68% | 4,126,119 | $35,608,407 | $33,173,997 | -$2,434,410 | -6.84% | |
| Bain Capital Life Sciences Investors, Llc | 2.42% | 3,110,000 | $26,839,300 | $25,004,400 | -$1,834,900 | -6.84% | |
| Aigh Capital Management Llc | 3.53% | 2,000,000 | $17,260,000 | $16,080,000 | -$1,180,000 | -6.84% | |
| Deerfield Management Company, L.P. | 0.20% | 2,000,000 | $17,260,000 | $16,080,000 | -$1,180,000 | -6.84% | |
| Vanguard Capital Management Llc | 0.00% | 1,783,342 | $15,390,241 | $14,338,070 | -$1,052,171 | -6.84% | |
| Balyasny Asset Management L.P. | 0.02% | 1,125,321 | $9,711,520 | $9,047,581 | -$663,939 | -6.84% | |
| Millennium Management Llc | 0.01% | 1,005,508 | $8,677,534 | $8,084,284 | -$593,250 | -6.84% | |
| Insight Holdings Group, Llc | 0.60% | 989,054 | $8,535,536 | $7,951,994 | -$583,542 | -6.84% | |
| Morgan Stanley | 0.00% | 977,289 | $8,434,004 | $7,857,404 | -$576,600 | -6.84% | |
| Blackrock, Inc. | 0.00% | 877,078 | $7,569,182 | $7,051,707 | -$517,475 | -6.84% | |
| Woodline Partners Lp | 0.03% | 845,325 | $7,295,155 | $6,796,413 | -$498,742 | -6.84% | |
| D. E. Shaw & Co., Inc. | 0.00% | 721,581 | $6,227,244 | $5,801,511 | -$425,733 | -6.84% | |
| Propel Bio Management, Llc | 3.52% | 644,421 | $5,585,588 | $5,181,145 | -$404,443 | -7.24% | |
| Mbb Public Markets I Llc | 0.63% | 614,477 | $5,302,937 | $4,940,395 | -$362,542 | -6.84% | |
| Marshall Wace, Llp | 0.01% | 605,512 | $5,225,570 | $4,868,316 | -$357,254 | -6.84% | |
| Susquehanna International Group, Llp | 0.01% | 577,600 | $4,984,688 | $4,643,904 | -$340,784 | -6.84% | |
| Adage Capital Partners Gp, L.L.C. | 0.01% | 500,000 | $4,315,000 | $4,020,000 | -$295,000 | -6.84% | |
| Ubs Group Ag | 0.00% | 449,750 | $3,881,342 | $3,615,990 | -$265,352 | -6.84% | |
| Geode Capital Management, Llc | 0.00% | 423,826 | $3,659,534 | $3,407,561 | -$251,973 | -6.89% | |
| Bnp Paribas Financial Markets | 0.00% | 412,032 | $3,555,836 | $3,312,737 | -$243,099 | -6.84% | |
| Renaissance Technologies LLC | Jim Simons | 0.00% | 367,492 | $3,171,456 | $2,954,636 | -$216,820 | -6.84% |
| Qube Research & Technologies Ltd | 0.00% | 333,692 | $2,879,762 | $2,682,884 | -$196,878 | -6.84% | |
| Vanguard Fiduciary Trust Co | 0.00% | 224,584 | $1,938,160 | $1,805,655 | -$132,505 | -6.84% | |
| Point72 Asset Management, L.P. | 0.00% | 222,929 | $1,923,877 | $1,792,349 | -$131,528 | -6.84% | |
| Goldman Sachs Group Inc | 0.00% | 212,910 | $1,837,413 | $1,711,796 | -$125,617 | -6.84% | |
| Charles Schwab Investment Management Inc | 0.00% | 211,088 | $1,821,689 | $1,697,148 | -$124,541 | -6.84% | |
| Burkehill Global Management, Lp | 0.09% | 200,000 | $1,726,000 | $1,608,000 | -$118,000 | -6.84% | |
| Invesco Ltd. | 0.00% | 186,674 | $1,610,997 | $1,500,859 | -$110,138 | -6.84% | |
| Two Sigma Investments, Lp | 0.00% | 181,615 | $1,567,337 | $1,460,185 | -$107,152 | -6.84% | |
| Simplify Asset Management Inc. | 0.02% | 173,106 | $1,493,905 | $1,391,772 | -$102,133 | -6.84% | |
| Td Asset Management Inc | 0.00% | 169,082 | $1,459,178 | $1,359,419 | -$99,759 | -6.84% | |
| Bridgeway Capital Management, Llc | 0.03% | 149,900 | $1,293,637 | $1,205,196 | -$88,441 | -6.84% | |
| Squarepoint Ops Llc | 0.00% | 146,978 | $1,268,420 | $1,181,703 | -$86,717 | -6.84% | |
| State Street Corp | 0.00% | 138,300 | $1,193,529 | $1,111,932 | -$81,597 | -6.84% | |
| Barclays Plc | 0.00% | 136,375 | $1,176,916 | $1,096,455 | -$80,461 | -6.84% | |
| Manufacturers Life Insurance Company, The | 0.00% | 134,530 | $1,160,994 | $1,081,621 | -$79,373 | -6.84% | |
| Stifel Financial Corp | 0.00% | 130,524 | $1,126,421 | $1,049,413 | -$77,008 | -6.84% | |
| Y-Intercept (Hong Kong) Ltd | 0.02% | 114,841 | $991,078 | $923,322 | -$67,756 | -6.84% | |
| Wells Fargo & Company/Mn | 0.00% | 114,399 | $987,263 | $919,768 | -$67,495 | -6.84% | |
| Wesbanco Bank Inc | 0.03% | 110,300 | $951,889 | $886,812 | -$65,077 | -6.84% | |
| Kera Capital Partners, Inc. | 0.11% | 108,083 | $932,756 | $868,987 | -$63,769 | -6.84% | |
| Jane Street Group, Llc | 0.00% | 104,214 | $899,367 | $837,881 | -$61,486 | -6.84% | |
| 683 Capital Management, Llc | 0.07% | 85,000 | $733,550 | $683,400 | -$50,150 | -6.84% | |
| Dimensional Fund Advisors Lp | 0.00% | 78,419 | $676,756 | $630,489 | -$46,267 | -6.84% | |
| Northern Trust Corp | 0.00% | 78,042 | $673,502 | $627,458 | -$46,044 | -6.84% | |
| Hudson Bay Capital Management Lp | 0.00% | 71,059 | $613,239 | $571,314 | -$41,925 | -6.84% | |
| Citadel Advisors Llc | 0.00% | 58,126 | $501,627 | $467,333 | -$34,294 | -6.84% | |
| Bank Of America Corp | 0.00% | 55,728 | $480,933 | $448,053 | -$32,880 | -6.84% | |
| Man Group Plc | 0.00% | 53,543 | $462,076 | $430,486 | -$31,590 | -6.84% |
Frequently asked questions about KYTX
Who owns the most KYTX stock?
The largest holders of KYTX are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for KYVERNA THERAPEUTICS INC (KYTX).
Is KYTX widely held by superinvestors?
Many widely followed stocks like KYTX appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly KYTX is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.